CapsoVision Wins FDA Clearance For AI Highlights Tool
(RTTNews) - Monday, CapsoVision, Inc. (CV) announced that the U.S. Food and Drug Administration has granted clearance for AI Highlights, its AI-assisted reading tool for the CapsoCam Plus system, designed to support capsule endoscopy review without the need for a separate AI platform.
It helps physicians recognize and mark images containing suspected abnormal lesions, which are highlighted and prioritized for physician review.
The company stated that the clearance represents a significant milestone in the continued evolution of the CapsoVision platform and its commitment to bringing integrated, AI-assisted technologies to physicians in the United States.
CV was trading at $6.53, down 1.88 percent on the Nasdaq.
Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.